These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8370919)

  • 21. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretibial mucin. Histologic patterns and clinical correlation.
    Somach SC; Helm TN; Lawlor KB; Bergfeld WF; Bass J
    Arch Dermatol; 1993 Sep; 129(9):1152-6. PubMed ID: 8363399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal cutaneous mucinosis in Graves disease: relation to pretibial myxedema.
    Kerns MJ; Mutasim DF
    Am J Dermatopathol; 2010 Apr; 32(2):196-7. PubMed ID: 19940747
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.
    Caron P; Imbert P; Dekeister C; Grunenwald S
    Ann Endocrinol (Paris); 2024 Apr; 85(2):100-103. PubMed ID: 37866430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
    Imai Y; Odajima R; Shimizu T; Shishiba Y
    Endocrinol Jpn; 1990 Oct; 37(5):749-52. PubMed ID: 1982261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment.
    Yu H; Jiang X; Pan M; Huang R
    Clin Nucl Med; 2014 Aug; 39(8):758-9. PubMed ID: 24830877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy.
    Garrity JA; Fatourechi V; Bergstralh EJ; Bartley GB; Beatty CW; DeSanto LW; Gorman CA
    Am J Ophthalmol; 1993 Nov; 116(5):533-47. PubMed ID: 8238212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome.
    Schwartz KM; Fatourechi V; Ahmed DD; Pond GR
    J Clin Endocrinol Metab; 2002 Feb; 87(2):438-46. PubMed ID: 11836263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endonasal endoscopic orbital decompression in patients with Graves' ophthalmopathy.
    Stiglmayer N; Mladina R; Tomić M; Tojagić M; Juri J; Bubas N; Mrazovac V
    Croat Med J; 2004 Jun; 45(3):318-22. PubMed ID: 15185426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elephantiasis Nostras Verrucosa: a rare thyroid dermopathy in Graves' disease.
    Kakati S; Doley B; Pal S; Deka UJ
    J Assoc Physicians India; 2005 Jun; 53():571-2. PubMed ID: 16121817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
    Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
    Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretibial myxedema as the initial manifestation of Graves' disease.
    Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical excision of pseudotumorous pretibial myxedema.
    Pingsmann A; Ockenfels HM; Patsalis T
    Foot Ankle Int; 1996 Feb; 17(2):107-10. PubMed ID: 8919410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful therapeutic approach in a patient with elephantiasic pretibial myxedema.
    Ferreira M; Zacaron LH; Valle AFD; Gamonal ACC
    An Bras Dermatol; 2020; 95(4):469-472. PubMed ID: 32461007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pretibial myxedema: pathogenetic features and clinical aspects].
    Sabanova EA; Fadeyev VV; Potekaev NN; Lvov AN
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):134-138. PubMed ID: 31271716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Preliminary findings].
    Antonelli A; Saracino A; Agostini S; Alberti B; Melosi A; Gambuzza C; Avantaggiato G; Baschieri L
    Clin Ter; 1992 Sep; 141(9 Pt 2):63-8. PubMed ID: 1281765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized myxedema of the toe: a rare presentation of graves' dermopathy.
    Hasani-Ranjbar S; Mohajeri-Tehrani MR
    Arch Iran Med; 2008 May; 11(3):326-9. PubMed ID: 18426326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orbital decompression for preservation of vision in Graves' ophthalmopathy.
    Girod DA; Orcutt JC; Cummings CW
    Arch Otolaryngol Head Neck Surg; 1993 Feb; 119(2):229-33. PubMed ID: 8427689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves' autoantibodies to extrathyroidal TSH receptor: their role in ophthalmopathy and pretibial myxedema.
    Rotella CM; Alvarez F; Kohn LD; Toccafondi R
    Acta Endocrinol Suppl (Copenh); 1987; 281():344-7. PubMed ID: 3475915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.